Apple shares fall after the iPhone maker’s guidance fails to meet investors’ high bar.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
ApplePalantirpharmaceuticalsPfizer
Open a keyword to see other news on the same topic.
Related tickers and likely impact
AAPL
• NeutralApple Inc.
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Information Technology |
| Industry | Technology Hardware, Storage & Peripherals |
| Market cap | $5.1T |
| Close on 11/02/2026 | 338.32 |
| Change that session | -1.83% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Pfizer Inc. Q3 2026 Earnings Call Summary
- Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction
Pfizer reported flat third-quarter revenue of $16.6 billion and raised its full-year outlook, with revenue guidance now $62.0 billion to $64.0 billion and adjusted EPS guidance $2.95 to $3.05. Eliquis rose 25% year over year to $2.52 billion, beating roughly $2.40 billion expected and offsetting lower COVID and Prevnar sales, with higher U.S. net price cited as a key driver. Reported diluted EPS fell to $0.56 from $0.62, while adjusted diluted EPS held at $0.87. Excluding Comirnaty and Paxlovid, revenue grew 7% operationally. The article notes that price-driven gains can be harder to repeat than demand-driven ones, especially with the Medicare negotiated price in effect for 2026.
- Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
Pfizer (PFE) reported third-quarter revenue of $16.6 billion, above the $15.9 billion analyst expectation, and adjusted EPS of $0.87 versus $0.73 estimates. It raised full-year adjusted EPS guidance to $2.95 to $3.05 from a prior $2.80 to $3, and expects savings of about $9.7 billion through 2029. Revenue from launched and acquired products rose 32% in the quarter, while the company generates less revenue from COVID products than in the past. The article argues the stock is undervalued, with a forward P/E of about 10 and a dividend yield of 5.6%, even though it is up more than 20% this year and still down more than 30% over five years.
- Pfizer hikes full-year outlook, taps company veteran as new CFO
Pfizer reported third-quarter adjusted earnings of 87 cents per share versus 73 cents expected and revenue of $16.58 billion versus $15.87 billion expected, and it raised its full-year outlook, citing strong year-to-date performance and ongoing cost cuts. Full-year revenue guidance rose to $62 billion to $64 billion from $60.5 billion to $62.5 billion, and adjusted EPS guidance rose to $2.95 to $3.05 per share from $2.80 to $3. Cecile Guegan, who has held various finance roles at the company over two decades, became chief financial officer this month after serving as interim CFO since August, when Dave Denton left to become CFO at Nike.
- Stocktwits Pharma Pulse: Biotech Beats The Broader Market — Novo, Pfizer And Moderna Earnings Up Next
Biotech stocks rose last week and beat the broader market, with IBB up 5%, XBI up 4% and XLV up 3%, while SPY fell 0.6% and QQQ dropped 2%. This week, Vertex reports on Monday after the close, with second-quarter sales of $49.6 million for Journavx and $76.4 million for Casgevy. Pfizer (PFE) and Amgen (AMGN) report on Tuesday, Novo Nordisk (NVO) on Wednesday, and Moderna (MRNA) on Friday. Investors will watch Wegovy pill sales, whether Pfizer's newer medicines can offset weaker COVID-related sales, and updates on Amgen's MariTide and Moderna's personalized cancer vaccine. Cancer research will also be presented at the Society for Immunotherapy of Cancer's annual meeting, running November 4 to 8 in Phoenix.
- Pfizer Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?
Pfizer shares, long overlooked despite solid fundamentals and an attractive valuation, have climbed 18% so far this year, their best performance since 2021, though they remain about 30% lower over five years. The article suggests investors may be rotating from tech into healthcare, citing recent moves in two exchange-traded funds. Pfizer's yield of 5.8% is more than five times the S&P 500 average of 1%. Its trailing P/E of 37 looks high because restructuring and impairment charges weigh on earnings, but its forward P/E of about 10 suggests the stock is still undervalued. The author believes the market will eventually recognise this, although long-term growth questions remain.
Related markets
Latest news
- [UPDATE] CNN projects Democrats will take the House from Republicans, President Trump denies responsibility
Democrat Chris Pappas won the New Hampshire Senate seat, defeating Republican John Sununu. AP projects Democrat Mark Warner will win re-election in Virginia over Bert Mizusawa, while Debbie Wasserman Schultz won the Florida 20th district House seat. CNN and AP project Jon Ossoff will be re-elected in Georgia over Mike Collins, but a runoff on December 1 would follow if no candidate wins a majority. Democrats also won Senate races in New Jersey, Illinois, Delaware, Massachusetts and Rhode Island. Early projections are not final results, and some close races may take hours or even days to decide.
- Democrats claim control of the US Senate
According to the AP, Democrats have won control of the Senate after Josh Turek won the Iowa race, bringing their total, including independents who caucus with them, to 51 seats. The shift could change the path of the stalled CLARITY Act, reshape committee leadership and bring closer scrutiny of Trump-linked crypto businesses and regulators' decisions. The CLARITY Act failed a Senate procedural vote 49 to 50 in September, and if it is not passed by January, the next Congress starts from scratch. Jerome de Tychey, president of Ethereum France, said nothing will pass without cross-partisan support and warned that the biggest risk for US crypto is becoming a partisan issue.
- Why Shake Shack Stock Jumped 20% in October
Shake Shack shares rose 20% in October according to S&P Global Market Intelligence, amid a broader rotation into restaurant stocks as investors sold AI stocks. The gain was supported by plans to enter Brazil through a licensing partnership, several positive analyst notes, including Morgan Stanley raising its price target from $74 to $79 and UBS lifting its target from $68 to $73, and a late-month jump tied to Nelson Peltz's buyout proposal for Wendy's. Shake Shack will report third-quarter earnings on Thursday, with analysts expecting revenue to grow 16% to $426.3 million and adjusted EPS to fall from $0.36 to $0.34. Investors will watch same-store sales growth and margins, as the company has struggled to turn revenue growth into profit growth.
- Financial markets turbulent, safe-haven assets gain favor, except gold
Volatility from the AI rally has pushed investors toward US Treasuries, the dollar, the Swiss franc and the yen, but gold has not attracted inflows. Gold fell below 4,000 USD/ounce, its lowest level in a year, while central bank gold purchases rose 42% in the third quarter to 321 tonnes. Since the US and Israel first attacked Iran, gold has lost about a quarter of its value and is down 9% year to date in USD terms, the weakest of 14 major asset classes in Bank of America's ranking. Standard Chartered finds the correlation between gold and the S&P 500 has risen to 0.48 on a three-month rolling basis and 0.69 over one month. The bank's analysts say that in the short term, the need to raise cash could lead investors to sell gold rather than buy more.
- Over 2.5 million tax codes stuck: Debt write-off is not enough, a streamlined dissolution path is needed
The Ministry of Finance says that as of 23 October 2026, over 2.5 million taxpayers had ceased operating without completing procedures to close their tax codes or no longer operated at their registered address, including about 643,000 in status 03 and nearly 1.88 million in status 06. The ministry proposes waiving business licence fees and late-payment interest and reducing penalties for late tax filings, but lawyer Nguyen Van Duoc argues the bigger bottleneck is reconstructing years of accounting records, which is nearly infeasible for firms dormant for 10-20 years. He proposes allowing retroactive dissolution dates tied to when the tax authority determines a firm is no longer operating, alongside a streamlined dissolution process. As an example, a firm inactive since 2007 faced more than VND 78.2 million in charges that could fall to VND 6.9 million under the draft. VTCA proposes classifying files and handling cases based on data.
- Asian FX gains as dollar falls on U.S. midterm results, yuan weakens on PBOC move
Most Asian currencies strengthened on Wednesday as the dollar retreated amid uncertainty over U.S. midterm results, while the yuan stayed weaker after Beijing moved to curb its recent rally. The Reserve Bank of Australia raised its cash rate by 25 basis points to 4.85%, its fifth increase this year and the highest level in 18 years, in a surprisingly divided 6-3 vote that fuelled expectations the tightening cycle may be nearing its end. The U.S. dollar index fell 0.5% to 101.34, the South Korean won gained 0.5% to 1,337.98 per dollar, and the yen strengthened 0.7% to 157.64 per dollar. Democrat Jon Ossoff won re-election in Georgia and Roy Cooper flipped a Republican-held Senate seat in North Carolina, while control of Congress remained uncertain, and the 10-year Treasury yield fell 4 basis points to 4.919%. Brent crude traded around $103.85 a barrel after falling about 1% to a near four-week low, as markets weighed diplomatic efforts to end the conflicts in Iran and Ukraine against the risk that further attacks disrupt supplies.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.